AtaiBeckley (ATAI) Current Deferred Revenue (2021 - 2026)
AtaiBeckley's (ATAI) quarterly Current Deferred Revenue came in at $1.5 million in Q1 2026, down 1.33% year-on-year from $1.5 million in Q1 2025, and down 2.89% quarter-over-quarter from $1.5 million in Q4 2025.
AtaiBeckley (ATAI) Current Deferred Revenue (2021 - 2026) Analysis & Trends
AtaiBeckley's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- On a quarterly basis, Current Deferred Revenue fell 1.33% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 1.33% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 111.37% from the prior year.
- Current Deferred Revenue was little changed at $575000.0 in Q3 2025, from $575000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $1.5 million in Q4 2025 and bottomed at $721000.0 in Q4 2024.
- The 3-year median for Current Deferred Revenue is $1.5 million (2025), against an average of $1.3 million.
- Across the five-year window, Current Deferred Revenue surged 111.37% in 2025 and slipped 1.33% in 2026, its largest moves.
- Year by year, Current Deferred Revenue stood at $721000.0 in 2024, then jumped by 111.37% to $1.5 million in 2025, then retreated by 2.89% to $1.5 million in 2026.
- Per Business Quant, the three latest ATAI Current Deferred Revenue figures stand at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 575,000.00 |
| Jun 30, 2025 | 575,000.00 |
| Mar 31, 2025 | 1.50 Mn |
| Mar 31, 2025 | 575,000.00 |
| Dec 31, 2024 | 721,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 120,000.00 |